ClinicalTrials.govpublic full text
UC-MSCs in the Treatment of Severe and Critical COVID-19 Patients With Refractory Hypoxia
mesenchymal stem cell, covid-19 pneumonia, umbilical cord mesenchymal stem cells, refractory hypoxia, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 899524
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.